SCHEMBL15460411

SCHEMBL15460411

COc1ccc(C2CC(c3cc(C)c(C)c(OC)c3)=NO2)cc1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.45
MIF P14174 4/20 0.43
MAOB P27338 3/20 0.43
CYP19A1 P11511 3/20 0.41
TP53 P04637 2/20 0.41
CYP3A4 P08684 2/20 0.41
XDH P47989 2/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PKM P14618 1/20 0.41
NPC1 O15118 1/20 0.41
CA12 O43570 1/20 0.41
KDM1A O60341 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A1 P04798 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5686355 0.87 TUBB4A (0.52) PTPN1MIFMAPTSMN1; SMN2ALDH1A1
SCHEMBL17366133 0.85 TUBB4A (0.47) PTPN1MIFCYP19A1TP53CYP3A4
SCHEMBL15460398 0.84 PTPN1 (0.43) PTPN1MIFMAOBMAPTSMN1; SMN2
SCHEMBL15460408 0.83 PTPN1 (0.42) PTPN1MIFMAOBMAPTSMN1; SMN2
SCHEMBL13643398 0.80 PTPN1 (0.43) PTPN1MIFMAOBCYP19A1TP53
SCHEMBL15463035 0.79 MAPT (0.48) PTPN1MIFMAOBMAPTSMN1; SMN2
SCHEMBL13660015 0.78 MIF (0.51) PTPN1MIFMAPTSMN1; SMN2ALDH1A1
SCHEMBL15460410 0.77 MAOA (0.56) MAOBMAPTHPGDALDH1A1PTGS2
SCHEMBL5689279 0.75 TUBB4A (0.49) PTPN1MIFMAPTHSD17B10IARS1
SCHEMBL16602594 0.75 DRD2 (0.37) PTPN1MIFMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9102638-B2 Amidobenzothiazoles and process for the preparation thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-08-11 US disclosed
US-8921552-B2 Benzothiazole hybrids useful as anticancer agents and process for the preparation thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2014-12-30 US disclosed
US-20140039190-A1 BENZOTHIAZOLE HYBRIDS USEFUL AS ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2014-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140039190-A1 BENZOTHIAZOLE HYBRIDS USEFUL AS ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF TP53, MCL1, SDHA PTPN1 4424/4885MIF 3592/4885MAOB 1683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.